R-bendamustine in the treatment of nodular lymphocyte predominant Hodgkin lymphoma-An extended follow-up

被引：2
|
作者：
Vuolio, Tero [1 ,2 ,3 ]
Kuittinen, Outi [3 ,4 ,5 ]
Vayrynen, Juha P. [6 ,7 ]
Teppo, Hanna-Riikka [6 ,7 ]
Prusil, Roosa E. I. [8 ]
Ramet, Maria [9 ]
Kuitunen, Hanne [10 ]
Paloneva, Timo [11 ]
Kuusisto, Milla E. L. [1 ,2 ,3 ]
机构：
[1] Univ Oulu, Oulu, Finland
[2] Oulu Univ Hosp, Oulu, Finland
[3] Univ Eastern Finland, Inst Clin Med, Fac Hlth Med, Kuopio, Finland
[4] Oulu Univ Hosp, Dept Oncol & Radiotherapy, Oulu, Finland
[5] Kuopio Univ Hosp, Canc Ctr, Kuopio, Finland
[6] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu, Dept Pathol, Oulu, Finland
[7] Univ Oulu, Translat Med Res Unit, Oulu, Finland
[8] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland
[9] Lansi Pohja Cent Hosp, Kemi, Finland
[10] Oulu Univ Hosp, Canc Ctr, Oulu, Finland
[11] Cent Ostrobothnian Cent Hosp, Kokkola, Finland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 202卷 / 04期
关键词：
RITUXIMAB; MANAGEMENT; THERAPY; DISEASE; TRIAL;
D O I：
10.1111/bjh.18896
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E24 / E26
页数：3
相关论文
共 50 条
  • [21] Coexisting and Clonally Identical Classic Hodgkin Lymphoma and Nodular Lymphocyte Predominant Hodgkin Lymphoma
    Song, Joo Y.
    Eberle, Franziska C.
    Xi, Liqiang
    Raffeld, Mark
    Rahma, Osama
    Wilson, Wyndham H.
    Dunleavy, Kieron
    Pittaluga, Stefania
    Jaffe, Elaine S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (05) : 767 - 772
  • [22] Metachronous and clonally related classic Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma
    Ding, Yi
    Campbell, Andrew
    Zhang, Xuan
    Fu, Kai
    Yuan, Ji
    PATHOLOGY, 2021, 53 (02) : 285 - 288
  • [23] Nodular Lymphocyte Predominant Hodgkin Lymphoma Diagnostic Pearls and Pitfalls
    Smith, Lauren B.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (10) : 1434 - 1439
  • [24] How I treat nodular lymphocyte predominant Hodgkin lymphoma
    Advani, Ranjana H.
    Hoppe, Richard T.
    BLOOD, 2013, 122 (26) : 4182 - 4188
  • [25] IF-RT alone remains as the Gold Standard for stage IA nodular lymphocyte-predominant Hodgkin Lymphoma
    Pilz, Karoline
    Jentsch, Christina
    Krause, Mechthild
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (06) : 428 - 430
  • [26] Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications
    Gloghini, Annunziata
    Bosco, Agata
    Ponzoni, Maurilio
    Spina, Michele
    Carbone, Antonino
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (02) : 217 - 223
  • [27] Familial nodular lymphocyte predominant Hodgkin lymphoma: Successful treatment with CHOP plus rituximab
    Unal, A
    Sari, I
    Deniz, K
    Ozkan, M
    Kontas, O
    Eser, B
    Cetin, M
    LEUKEMIA & LYMPHOMA, 2005, 46 (11) : 1613 - 1617
  • [28] Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment
    Eichenauer, Dennis A.
    Hartmann, Sylvia
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (08) : 607 - 615
  • [29] Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
    Al-Mansour, Mubarak
    Connors, Joseph M.
    Gascoyne, Randy D.
    Skinnider, Brian
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 793 - 799
  • [30] High Familial Risk in Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Saarinen, Silva
    Pukkala, Eero
    Vahteristo, Pia
    Makinen, Markus J.
    Franssila, Kaarle
    Aaltonen, Lauri A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (07) : 938 - 943
12345